Table 1:

Baseline characteristics.

Baseline Characteristics	No HTN (n=9)	Controlled HTN (n=12)	Uncontrolled HTN (n=16)
Age – yr.	63 ± 10	65 ± 10	68 ± 7
Male/Female – n (%)	8 (89%)	11 (92%)	14 (88%)
CABG only – n (%)	7 (78%)	6 (50%)	12 (75%)
Valve surgery only – n (%)	1 (11%)	3 (25%)	3 (19%)
CABG + valve surgery - n (%)	1 (11%)	3 (25%)	1 (6%)
HbA1c (%)	6.2 ± 1.6	6.9 ± 1.3	6.2 ± 0.8
BMI (kg/m2)	27.6 ± 5.7	32.4 ± 7.0	31.2 ± 4.6
CPB Time (min)	92 ± 47	141 ± 57	118 ± 61
Cross Clamp Time (min)	71 ± 40	107 ± 43	95 ± 51
Systolic BP (mmHg)	119 ± 10	117 ± 9	138 ± 6
Diastolic BP (mmHg)	72 ± 5	69 ± 6	77 ± 7
Anti-hypertensive drug class
ACEi – n (%)	0 (0%)	5 (42%)	6 (38%)
ARB – n (%)	0 (0%)	2 (17%)	6 (38%)
Calcium Channel Blocker – n (%)	0 (0%)	3 (25%)	5 (31%)
Beta Blocker – n (%)	1 (11%)	10 (83%)	9 (56%)
Thiazide – n (%)	0 (0%)	3 (25%)	4 (25%)
Loop Diuretic – n (%)	0 (0%)	3 (25%)	0 (0%)

Categorical variables presented as no. (%); Continuous variables presented as mean ± standard deviation; Abbreviations: HTN = hypertension; CABG = coronary artery bypass surgery; AVR = aortic valve replacement; MVR = mitral valve replacement; BP = blood pressure; HbA1c = hemoglobin A1c; BMI = body mass index; CPB = cardiopulmonary bypass; ACEi = angiotensin converting enzyme inhibitor; ARB = angiotensin II receptor blocker